Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> Italian Authorities Investigating Senior WHO Official Over Suppression Of Report On Italy’s Pandemic Performance; Coverup Extended ‘Higher Up’ Than Imagined 12/04/2021 Elaine Ruth Fletcher Italian prosecutors in the city of Bergamo, the epicentre of the country’s first COVID wave, are reportedly investigating Ranieri Guerra, a senior World Health Organization advisor, for misleading testimony and his role in the suppression of a WHO report into Italy’s coronavirus response “An Unprecedented Challenge“- which contained critical material about the Italian government’s […] Continue reading -> WHO Calls For Global ‘Reality Check’ As Cases Surge And Countries Abandon Basics 12/04/2021 Kerry Cullinan The World Health Organization (WHO) has called for a global “reality check” as COVID-19 infections increased by 4.4 million in the past week, with countries and individuals abandoning proven methods to protect themselves. “This is not the situation we want to be in 16 months into a pandemic, where we have proven control measures. It […] Continue reading -> International Scientists Call On WHO To Conduct “Full” Investigation Into Origins of COVID-19 09/04/2021 Svĕt Lustig Vijay The WHO and its member states must take swift action to enable a transparent, independent and rigorous investigation into the origins of the SARS-CoV-2 virus, said two dozen international scientists in their second open letter. The letter – released on Wednesday by 24 scientists and researchers across Europe, the United States, and Japan – comes […] Continue reading -> European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> As Countries Worldwide Face Shortages – Appeal for Equitable COVID-19 Vaccine Access on World Health Day 06/04/2021 Kerry Cullinan Some of the world’s smallest countries joined the World Health Organization (WHO) to appeal for equitable access to COVID-19 vaccines on the eve of World Health Day – as the pipeline of global vaccine supplies to low- and middle-income countries risk drying up for the coming few months. Barbados Prime Minister Mia Amor Mottley told […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> Italian Authorities Investigating Senior WHO Official Over Suppression Of Report On Italy’s Pandemic Performance; Coverup Extended ‘Higher Up’ Than Imagined 12/04/2021 Elaine Ruth Fletcher Italian prosecutors in the city of Bergamo, the epicentre of the country’s first COVID wave, are reportedly investigating Ranieri Guerra, a senior World Health Organization advisor, for misleading testimony and his role in the suppression of a WHO report into Italy’s coronavirus response “An Unprecedented Challenge“- which contained critical material about the Italian government’s […] Continue reading -> WHO Calls For Global ‘Reality Check’ As Cases Surge And Countries Abandon Basics 12/04/2021 Kerry Cullinan The World Health Organization (WHO) has called for a global “reality check” as COVID-19 infections increased by 4.4 million in the past week, with countries and individuals abandoning proven methods to protect themselves. “This is not the situation we want to be in 16 months into a pandemic, where we have proven control measures. It […] Continue reading -> International Scientists Call On WHO To Conduct “Full” Investigation Into Origins of COVID-19 09/04/2021 Svĕt Lustig Vijay The WHO and its member states must take swift action to enable a transparent, independent and rigorous investigation into the origins of the SARS-CoV-2 virus, said two dozen international scientists in their second open letter. The letter – released on Wednesday by 24 scientists and researchers across Europe, the United States, and Japan – comes […] Continue reading -> European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> As Countries Worldwide Face Shortages – Appeal for Equitable COVID-19 Vaccine Access on World Health Day 06/04/2021 Kerry Cullinan Some of the world’s smallest countries joined the World Health Organization (WHO) to appeal for equitable access to COVID-19 vaccines on the eve of World Health Day – as the pipeline of global vaccine supplies to low- and middle-income countries risk drying up for the coming few months. Barbados Prime Minister Mia Amor Mottley told […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> Italian Authorities Investigating Senior WHO Official Over Suppression Of Report On Italy’s Pandemic Performance; Coverup Extended ‘Higher Up’ Than Imagined 12/04/2021 Elaine Ruth Fletcher Italian prosecutors in the city of Bergamo, the epicentre of the country’s first COVID wave, are reportedly investigating Ranieri Guerra, a senior World Health Organization advisor, for misleading testimony and his role in the suppression of a WHO report into Italy’s coronavirus response “An Unprecedented Challenge“- which contained critical material about the Italian government’s […] Continue reading -> WHO Calls For Global ‘Reality Check’ As Cases Surge And Countries Abandon Basics 12/04/2021 Kerry Cullinan The World Health Organization (WHO) has called for a global “reality check” as COVID-19 infections increased by 4.4 million in the past week, with countries and individuals abandoning proven methods to protect themselves. “This is not the situation we want to be in 16 months into a pandemic, where we have proven control measures. It […] Continue reading -> International Scientists Call On WHO To Conduct “Full” Investigation Into Origins of COVID-19 09/04/2021 Svĕt Lustig Vijay The WHO and its member states must take swift action to enable a transparent, independent and rigorous investigation into the origins of the SARS-CoV-2 virus, said two dozen international scientists in their second open letter. The letter – released on Wednesday by 24 scientists and researchers across Europe, the United States, and Japan – comes […] Continue reading -> European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> As Countries Worldwide Face Shortages – Appeal for Equitable COVID-19 Vaccine Access on World Health Day 06/04/2021 Kerry Cullinan Some of the world’s smallest countries joined the World Health Organization (WHO) to appeal for equitable access to COVID-19 vaccines on the eve of World Health Day – as the pipeline of global vaccine supplies to low- and middle-income countries risk drying up for the coming few months. Barbados Prime Minister Mia Amor Mottley told […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Italian Authorities Investigating Senior WHO Official Over Suppression Of Report On Italy’s Pandemic Performance; Coverup Extended ‘Higher Up’ Than Imagined 12/04/2021 Elaine Ruth Fletcher Italian prosecutors in the city of Bergamo, the epicentre of the country’s first COVID wave, are reportedly investigating Ranieri Guerra, a senior World Health Organization advisor, for misleading testimony and his role in the suppression of a WHO report into Italy’s coronavirus response “An Unprecedented Challenge“- which contained critical material about the Italian government’s […] Continue reading -> WHO Calls For Global ‘Reality Check’ As Cases Surge And Countries Abandon Basics 12/04/2021 Kerry Cullinan The World Health Organization (WHO) has called for a global “reality check” as COVID-19 infections increased by 4.4 million in the past week, with countries and individuals abandoning proven methods to protect themselves. “This is not the situation we want to be in 16 months into a pandemic, where we have proven control measures. It […] Continue reading -> International Scientists Call On WHO To Conduct “Full” Investigation Into Origins of COVID-19 09/04/2021 Svĕt Lustig Vijay The WHO and its member states must take swift action to enable a transparent, independent and rigorous investigation into the origins of the SARS-CoV-2 virus, said two dozen international scientists in their second open letter. The letter – released on Wednesday by 24 scientists and researchers across Europe, the United States, and Japan – comes […] Continue reading -> European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> As Countries Worldwide Face Shortages – Appeal for Equitable COVID-19 Vaccine Access on World Health Day 06/04/2021 Kerry Cullinan Some of the world’s smallest countries joined the World Health Organization (WHO) to appeal for equitable access to COVID-19 vaccines on the eve of World Health Day – as the pipeline of global vaccine supplies to low- and middle-income countries risk drying up for the coming few months. Barbados Prime Minister Mia Amor Mottley told […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Calls For Global ‘Reality Check’ As Cases Surge And Countries Abandon Basics 12/04/2021 Kerry Cullinan The World Health Organization (WHO) has called for a global “reality check” as COVID-19 infections increased by 4.4 million in the past week, with countries and individuals abandoning proven methods to protect themselves. “This is not the situation we want to be in 16 months into a pandemic, where we have proven control measures. It […] Continue reading -> International Scientists Call On WHO To Conduct “Full” Investigation Into Origins of COVID-19 09/04/2021 Svĕt Lustig Vijay The WHO and its member states must take swift action to enable a transparent, independent and rigorous investigation into the origins of the SARS-CoV-2 virus, said two dozen international scientists in their second open letter. The letter – released on Wednesday by 24 scientists and researchers across Europe, the United States, and Japan – comes […] Continue reading -> European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> As Countries Worldwide Face Shortages – Appeal for Equitable COVID-19 Vaccine Access on World Health Day 06/04/2021 Kerry Cullinan Some of the world’s smallest countries joined the World Health Organization (WHO) to appeal for equitable access to COVID-19 vaccines on the eve of World Health Day – as the pipeline of global vaccine supplies to low- and middle-income countries risk drying up for the coming few months. Barbados Prime Minister Mia Amor Mottley told […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
International Scientists Call On WHO To Conduct “Full” Investigation Into Origins of COVID-19 09/04/2021 Svĕt Lustig Vijay The WHO and its member states must take swift action to enable a transparent, independent and rigorous investigation into the origins of the SARS-CoV-2 virus, said two dozen international scientists in their second open letter. The letter – released on Wednesday by 24 scientists and researchers across Europe, the United States, and Japan – comes […] Continue reading -> European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> As Countries Worldwide Face Shortages – Appeal for Equitable COVID-19 Vaccine Access on World Health Day 06/04/2021 Kerry Cullinan Some of the world’s smallest countries joined the World Health Organization (WHO) to appeal for equitable access to COVID-19 vaccines on the eve of World Health Day – as the pipeline of global vaccine supplies to low- and middle-income countries risk drying up for the coming few months. Barbados Prime Minister Mia Amor Mottley told […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> As Countries Worldwide Face Shortages – Appeal for Equitable COVID-19 Vaccine Access on World Health Day 06/04/2021 Kerry Cullinan Some of the world’s smallest countries joined the World Health Organization (WHO) to appeal for equitable access to COVID-19 vaccines on the eve of World Health Day – as the pipeline of global vaccine supplies to low- and middle-income countries risk drying up for the coming few months. Barbados Prime Minister Mia Amor Mottley told […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
As Countries Worldwide Face Shortages – Appeal for Equitable COVID-19 Vaccine Access on World Health Day 06/04/2021 Kerry Cullinan Some of the world’s smallest countries joined the World Health Organization (WHO) to appeal for equitable access to COVID-19 vaccines on the eve of World Health Day – as the pipeline of global vaccine supplies to low- and middle-income countries risk drying up for the coming few months. Barbados Prime Minister Mia Amor Mottley told […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> Posts navigation Older postsNewer posts